Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'

J Hepatol. 2020 Sep;73(3):718-719. doi: 10.1016/j.jhep.2020.04.039. Epub 2020 May 6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections*
  • Humans
  • Liver Diseases*
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2